AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides

BackgroundProtein aggregation correlates with the development of several debilitating human disorders of growing incidence, such as Alzheimer's and Parkinson's diseases. On the biotechnological side, protein production is often hampered by the accumulation of recombinant proteins into aggregates. Thus, the development of methods to anticipate the aggregation properties of polypeptides is receiving increasing attention. AGGRESCAN is a web-based software for the prediction of aggregation-prone segments in protein sequences, the analysis of the effect of mutations on protein aggregation propensities and the comparison of the aggregation properties of different proteins or protein sets.ResultsAGGRESCAN is based on an aggregation-propensity scale for natural amino acids derived from in vivo experiments and on the assumption that short and specific sequence stretches modulate protein aggregation. The algorithm is shown to identify a series of protein fragments involved in the aggregation of disease-related proteins and to predict the effect of genetic mutations on their deposition propensities. It also provides new insights into the differential aggregation properties displayed by globular proteins, natively unfolded polypeptides, amyloidogenic proteins and proteins found in bacterial inclusion bodies.ConclusionBy identifying aggregation-prone segments in proteins, AGGRESCAN http://bioinf.uab.es/aggrescan/ shall facilitate (i) the identification of possible therapeutic targets for anti-depositional strategies in conformational diseases and (ii) the anticipation of aggregation phenomena during storage or recombinant production of bioactive polypeptides or polypeptide sets.

[1]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[2]  T. Iwatsubo,et al.  Biochemical characterization of the core structure of alpha-synuclein filaments. , 2002, The Journal of biological chemistry.

[3]  V. Turk,et al.  In vitro study of stability and amyloid‐fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1 , 2005, Protein Science.

[4]  Robert G Griffin,et al.  Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Kovacs,et al.  Characterization of spherical amyloid protein from a prolactin-producing pituitary adenoma , 1996, Acta Neuropathologica.

[6]  Yuji Goto,et al.  Amyloidogenic synthetic peptides of beta2-microglobulin--a role of the disulfide bond. , 2003, Biochemical and biophysical research communications.

[7]  Meital Reches,et al.  Amyloidogenic hexapeptide fragment of medin: homology to functional islet amyloid polypeptide fragments , 2004, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[8]  Angelo Fontana,et al.  A highly amyloidogenic region of hen lysozyme. , 2004, Journal of molecular biology.

[9]  M. Nagao,et al.  Analysis of the Secondary Structure of β-Amyloid (Aβ42) Fibrils by Systematic Proline Replacement* , 2004, Journal of Biological Chemistry.

[10]  Michel Goedert,et al.  Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.

[11]  P. Fraser,et al.  Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis. , 2003, Journal of structural biology.

[12]  P. Lansbury,et al.  Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.

[13]  Fabrizio Chiti,et al.  Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Christine Wurth,et al.  Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis. , 2002, Journal of molecular biology.

[15]  Huilin Li,et al.  Structural Role of Glycine in Amyloid Fibrils Formed from Transmembrane α-Helices† , 2005 .

[16]  C. Dobson,et al.  Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.

[17]  J. Liepnieks,et al.  Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. , 1988, Biochemical and biophysical research communications.

[18]  Ronald Wetzel,et al.  Kinetic analysis of beta-amyloid fibril elongation. , 2004, Analytical biochemistry.

[19]  R. Berry,et al.  Tau polymerization: role of the amino terminus. , 2003, Biochemistry.

[20]  M. Baumann,et al.  Amphoterin includes a sequence motif which is homologous to the Alzheimer's beta-amyloid peptide (Abeta), forms amyloid fibrils in vitro, and binds avidly to Abeta. , 2001, Biochemistry.

[21]  E. Mandelkow,et al.  Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.

[22]  L. Tjernberg,et al.  Proteolytic generation and aggregation of peptides from transmembrane regions: lung surfactant protein C and amyloid β-peptide , 2004, Cellular and Molecular Life Sciences CMLS.

[23]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[24]  C. Betsholtz,et al.  Islet amyloid polypeptide — a novel controversy in diabetes research , 1992, Diabetologia.

[25]  D. Brems,et al.  Inverse Relationship of Protein Concentration and Aggregation , 2002, Pharmaceutical Research.

[26]  L. Serrano,et al.  A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. , 2004, Journal of molecular biology.

[27]  E. Mandelkow,et al.  Structure, Stability, and Aggregation of Paired Helical Filaments from Tau Protein and FTDP-17 Mutants Probed by Tryptophan Scanning Mutagenesis* , 2002, The Journal of Biological Chemistry.

[28]  Amedeo Caflisch,et al.  Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences , 2005, Protein science : a publication of the Protein Society.

[29]  A. Fink Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.

[30]  L. Serrano,et al.  Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils. , 2002, Journal of molecular biology.

[31]  J. Liepnieks,et al.  Renal amyloidosis with a frame shift mutation in fibrinogen aalpha-chain gene producing a novel amyloid protein. , 1997, Blood.

[32]  Susan Jones,et al.  Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro. , 2003, Journal of molecular biology.

[33]  Thorsten Lührs,et al.  Correlation of structural elements and infectivity of the HET-s prion , 2005, Nature.

[34]  C. Dobson,et al.  High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Forloni,et al.  Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. , 1999, The Biochemical journal.

[36]  David Eisenberg,et al.  Structural models of amyloid-like fibrils. , 2006, Advances in protein chemistry.

[37]  S. Kahn,et al.  Hyperproinsulinemia and Amyloid in NIDDM: Clues to Etiology of Islet β-Cell Dysfunction? , 1989, Diabetes.

[38]  Brigida Bochicchio,et al.  Supramolecular Amyloid-like Assembly of the Polypeptide Sequence Coded by Exon 30 of Human Tropoelastin* , 2005, Journal of Biological Chemistry.

[39]  Ueli Aebi,et al.  The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. , 2005, Journal of molecular biology.

[40]  A. Villaverde,et al.  Protein quality in bacterial inclusion bodies. , 2006, Trends in biotechnology.

[41]  C. Dobson,et al.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.

[42]  D. Baker,et al.  The 3D profile method for identifying fibril-forming segments of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[44]  Christopher M. Dobson,et al.  Protein-misfolding diseases: Getting out of shape , 2002, Nature.

[45]  Ralf Langen,et al.  Template-assisted filament growth by parallel stacking of tau. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Naoki Yamamoto,et al.  Environment‐ and mutation‐dependent aggregation behavior of Alzheimer amyloid β‐protein , 2004, Journal of neurochemistry.

[47]  Ehud Gazit,et al.  Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide , 2001, The Journal of Biological Chemistry.

[48]  J. Wade,et al.  A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. , 2007, Journal of molecular biology.

[49]  B. Austen,et al.  Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils. , 2001, Journal of Molecular Biology.

[50]  David Eisenberg,et al.  A systematic screen of beta(2)-microglobulin and insulin for amyloid-like segments. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[51]  L. Serpell,et al.  Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. , 2004, FEBS letters.

[52]  D. Selkoe,et al.  Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases , 2004, Nature Cell Biology.

[53]  Adam Smith Protein misfolding , 2003, Nature.

[54]  C M Dobson,et al.  Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. , 2000, Journal of molecular biology.

[55]  R. Nussinov,et al.  Hot regions in protein--protein interactions: the organization and contribution of structurally conserved hot spot residues. , 2005, Journal of molecular biology.

[56]  Ying Xu,et al.  Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. , 2004, Journal of molecular biology.

[57]  Salvador Ventura,et al.  Prediction of "hot spots" of aggregation in disease-linked polypeptides , 2005, BMC Structural Biology.

[58]  Susan Idicula-Thomas,et al.  Understanding the relationship between the primary structure of proteins and their amyloidogenic propensity: clues from inclusion body formation. , 2005, Protein engineering, design & selection : PEDS.

[59]  W. Kamphorst,et al.  A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease , 2002, Annals of neurology.

[60]  E. Yılmaz,et al.  Genetic Risk Factors of Amyloidogenesis in Familial Mediterranean Fever , 2005, American Journal of Nephrology.

[61]  R. Berry,et al.  Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  S. Greenberg,et al.  Pathogenic effects of D23N Iowa mutant amyloid beta -protein. , 2001, The Journal of biological chemistry.

[63]  C M Dobson,et al.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[64]  A. Villaverde,et al.  Protein aggregation in recombinant bacteria: biological role of inclusion bodies , 2003, Biotechnology Letters.

[65]  Andreas Hoenger,et al.  De novo designed peptide-based amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[66]  David Eisenberg,et al.  A systematic screen of β2-microglobulin and insulin for amyloid-like segments , 2006 .

[67]  Michele Vendruscolo,et al.  Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. , 2004, Journal of molecular biology.

[68]  R. Leapman,et al.  A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[69]  K. Tomoo,et al.  Aggregation analysis of the microtubule binding domain in tau protein by spectroscopic methods. , 2003, Journal of biochemistry.

[70]  Fred E. Cohen,et al.  Therapeutic approaches to protein-misfolding diseases , 2003, Nature.

[71]  M. Nagao,et al.  Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement. , 2004, The Journal of biological chemistry.

[72]  Salvador Ventura,et al.  Mutagenesis of the central hydrophobic cluster in Abeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities. , 2006, The FEBS journal.

[73]  B. Ghetti,et al.  Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Michele Vendruscolo,et al.  Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.

[75]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[76]  T. Sanke,et al.  Missense Mutation of Amylin Gene (S20G) in Japanese NIDDM Patients , 1996, Diabetes.

[77]  R. Norton,et al.  The Val-210-Ile pathogenic Creutzfeldt-Jakob disease mutation increases both the helical and aggregation propensities of a sequence corresponding to helix-3 of PrP(C). , 2001, Biochimica et biophysica acta.

[78]  Bertrand Morel,et al.  A single mutation induces amyloid aggregation in the alpha-spectrin SH3 domain: analysis of the early stages of fibril formation. , 2006, Journal of molecular biology.

[79]  Christopher M Dobson,et al.  Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[80]  Michel Goedert,et al.  Mutation E46K increases phospholipid binding and assembly into filaments of human α‐synuclein , 2004 .

[81]  D. Craik,et al.  1H NMR analysis of fibril-forming peptide fragments of transthyretin. , 2009, International journal of peptide and protein research.

[82]  Barry M Wise,et al.  Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides. , 2006, Biochemistry.

[83]  Christopher M. Dobson,et al.  The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[84]  S. Prusiner,et al.  Solid-state NMR structural studies of the fibril form of a mutant mouse prion peptide PrP89-143(P101L). , 2006, Solid state nuclear magnetic resonance.

[85]  J. McLaurin,et al.  Biophysical characterization of longer forms of amyloid beta peptides: possible contribution to flocculent plaque formation , 2005, Journal of neurochemistry.

[86]  Huilin Li,et al.  Structural role of glycine in amyloid fibrils formed from transmembrane alpha-helices. , 2005, Biochemistry.

[87]  P. Westermark,et al.  The N-terminal segment of protein AA determines its fibrillogenic property. , 1992, Biochemical and biophysical research communications.

[88]  Salvador Ventura,et al.  Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[89]  T. Clackson,et al.  A hot spot of binding energy in a hormone-receptor interface , 1995, Science.

[90]  H. Vinters,et al.  Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. , 1996, Biochemistry.

[91]  K. Iwata,et al.  3D structure of amyloid protofilaments of β2-microglobulin fragment probed by solid-state NMR , 2006, Proceedings of the National Academy of Sciences.

[92]  U. Aebi,et al.  Full-length rat amylin forms fibrils following substitution of single residues from human amylin. , 2003, Journal of molecular biology.

[93]  C. Dobson,et al.  Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[94]  J Q Trojanowski,et al.  A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.

[95]  Michail Yu. Lobanov,et al.  Prediction of Amyloidogenic and Disordered Regions in Protein Chains , 2006, PLoS Comput. Biol..

[96]  G. Irvine,et al.  Identification of the region of non‐Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity , 2001, Journal of neurochemistry.

[97]  H. Vinters,et al.  Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence† , 1996 .

[98]  Elena Orlova,et al.  Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.

[99]  S. Greenberg,et al.  Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein* , 2001, The Journal of Biological Chemistry.

[100]  L. Serrano,et al.  Protein aggregation and amyloidosis: confusion of the kinds? , 2006, Current opinion in structural biology.

[101]  David Eisenberg,et al.  An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[102]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[103]  E. Mandelkow,et al.  Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. , 2002, Biochemistry.

[104]  T. Iwatsubo,et al.  Biochemical Characterization of the Core Structure of α-Synuclein Filaments* , 2002, The Journal of Biological Chemistry.